GH Research PLC(GHRS) - 2021 Q4 - Annual Report

Exhibit 99.1 GH Research Reports Full Year 2021 Financial Results and Provides Business Updates Dublin, Ireland, March 28, 2022 – GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders, today reported financial results for the full year ended December 31, 2021 and gave updates on its business. Fourth Quarter 2021 Business Highlights In December 2021, we reported the successful outcome of the Phase 2 part of ...